Records containing: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-20Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors
-
CLINICAL_TRIALS study record update · 2023-10-03A COG Study for Collecting and Banking Ewing Sarcoma Specimens
-
CLINICAL_TRIALS study record update · 2017-11-20A Pilot Study of the Utility of 18F-FLT-PET and Diffusion-Weighted MRI for Surgical Planning, Radiotherapy Target Delineation, and Treatment Response Evaluation in Ewing Sarcoma Patients
-
CLINICAL_TRIALS study record update · 2017-05-12A Phase II Study of Single Agent Depsipeptide (FK228) in Metastatic or Unresectable Soft Tissue Sarcomas
-
CLINICAL_TRIALS study record update · 2016-10-19Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-07-22A Phase 1B/II Study of GDC-0449 (NSC 747691) in Combination With RO4929097, a Gamma-Secretase Inhibitor (GSI) in Advanced/Metastatic Sarcomas
-
CLINICAL_TRIALS study record update · 2015-01-09A Pilot Study of Whole-body MRI-guided Intensity Modulated Radiation Therapy Combined With Systemic Chemotherapy Followed by High-Dose Chemotherapy With Busulfan, Melphalan and Topotecan and Stem Cell Rescue in Patients With Poor Risk Ewing's Sarcoma
-
CLINICAL_TRIALS study record update · 2014-03-17A Phase II Clinical and Correlative Study of BAY 43-9006 (Sorafenib) IND 69,896 in Sarcoma
-
CLINICAL_TRIALS study record update · 2013-06-24A Groupwide Biology and Banking Study for Ewing Sarcoma
-
CLINICAL_TRIALS study record update · 2013-06-04A Multicenter Phase I Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) in Patients With Recurrent/Refractory Pediatric Solid Tumors (Ewing's Sarcoma, Desmoplastic Small Round Cell Tumor, Osteosarcoma, Neuroblastoma, and Rhabdomyosarcoma) and Leukemia
-
CLINICAL_TRIALS study record update · 2013-02-07A Phase I Trial of Weekly 17-Allylamino-17 Demethoxygeldanamycin